Dr. Stephen R. Byrn, Phd Of Purdue University, To Keynote At Controlled & Modfied Drug Release Event

NEW YORK - April 13, 2015 - PRLog -- Curtis & Coulter, LLC announces that Dr. Stephen Byrn will be speaking at the 2^nd Controlled & Modified Drug Release, May 13-14, 2015 at the Hilton Philadelphia at Penn’s Landing. He will join a panel of experts on Accelerating Time to Market Through Innovation in Formulation Design and Drug Delivery. The program will also feature a FDA Regulatory Update regarding Guidance on Pharmacokinetics and Clinical Evaluation of Sustained & Modified Release Dosage Forms.

Other conference sessions will include:

New approaches in modified release / modeling & simulation in modified release
Advances in topical and transdermal delivery
Application of in-vivo and in-silico modeling
Understanding and establishing the right conditions for IVIVC correlation
Parenteral controlled & sustained release
Creating next generation products: Evaluating innovations in oral drug formulation and delivery technologies
Combining in-vivo animal models with physiologically-based PBPK modeling

# # #

Curtis & Coulter, LLC is a leading provider of business information to the Pharmaceutical and Biotech Industries.

A limited number of press passes are available for this event.